{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:39:29Z","timestamp":1793410769595,"version":"4.5.0"},"reference-count":19,"publisher":"BMJ","issue":"1","funder":[{"DOI":"10.13039\/501100015378","name":"Shanghai University of Medicine and Health Sciences","doi-asserted-by":"publisher","award":["SSF-23-07-002"],"award-info":[{"award-number":["SSF-23-07-002"]}],"id":[{"id":"10.13039\/501100015378","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Eur J Hosp Pharm"],"accepted":{"date-parts":[[2025,1,20]]},"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1136\/ejhpharm-2024-004352","type":"journal-article","created":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T11:55:22Z","timestamp":1739015722000},"page":"50-55","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":9,"title":["Evaluation of statin-induced muscle and liver adverse drug reactions in the Chinese population: a retrospective analysis of clinical trial data from 1992 to 2023"],"prefix":"10.1136","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8071-0624","authenticated-orcid":false,"given":"Leo","family":"Tsui","sequence":"first","affiliation":[{"name":"School of Pharmacy, Shanghai University of Medicine and Health Sciences, Shanghai, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Shanghai University of Medicine and Health Sciences, Shanghai, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuyun","family":"Fan","sequence":"additional","affiliation":[{"name":"PLA Navy Characteristic Medical Center, Shanghai, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yule","family":"Huang","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Shanghai University of Medicine and Health Sciences, Shanghai, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwen","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Shanghai University of Medicine and Health Sciences, Shanghai, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongjian","family":"Fang","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Shanghai University of Medicine and Health Sciences, Shanghai, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xie","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Shanghai University of Medicine and Health Sciences, Shanghai, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,2,8]]},"reference":[{"key":"2025122321350579000_33.1.50.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67394-1"},{"key":"2025122321350579000_33.1.50.2","doi-asserted-by":"publisher","DOI":"10.6515\/acs20160611a"},{"key":"2025122321350579000_33.1.50.3","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.118.312782"},{"key":"2025122321350579000_33.1.50.4","doi-asserted-by":"crossref","DOI":"10.1186\/s12944-020-01212-y","article-title":"Differential effects of Chinese high-fat dietary habits on lipid metabolism: mechanisms and health implications","volume":"19","author":"Yan","year":"2020","journal-title":"Lipids Health Dis"},{"key":"2025122321350579000_33.1.50.5","doi-asserted-by":"crossref","first-page":"199","DOI":"10.5551\/jat.40204","article-title":"Statin Responses in Chinese Patients","volume":"25","author":"Tomlinson","year":"2018","journal-title":"J Atheroscler Thromb"},{"key":"2025122321350579000_33.1.50.6","doi-asserted-by":"publisher","DOI":"10.5551\/jat.RV16004"},{"key":"2025122321350579000_33.1.50.7","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv043"},{"key":"2025122321350579000_33.1.50.8","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-068915","article-title":"Adverse drug reactions of non-statin antihyperlipidaemic drugs in China from 1989 to 2019: a national database analysis","volume":"13","author":"Tsui","year":"2023","journal-title":"BMJ Open"},{"key":"2025122321350579000_33.1.50.9","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm-2023-003929"},{"key":"2025122321350579000_33.1.50.10","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/31.4.839"},{"key":"2025122321350579000_33.1.50.11","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2014.125"},{"key":"2025122321350579000_33.1.50.12","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.12659\/MSM.893007","article-title":"SLCO1B1 polymorphism is not associated with risk of statin-induced myalgia\/myopathy in a Czech population","volume":"21","author":"Hub\u00e1\u010dek","year":"2015","journal-title":"Med Sci Monit"},{"key":"2025122321350579000_33.1.50.13","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/eurjpc\/zwae009","article-title":"PCSK9 genetic variants and risk of vascular and non-vascular diseases in Chinese and UK populations","volume":"31","author":"Holmes","year":"2024","journal-title":"Eur J Prev Cardiol"},{"key":"2025122321350579000_33.1.50.14","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht055"},{"key":"2025122321350579000_33.1.50.15","doi-asserted-by":"publisher","DOI":"10.1161\/atv.0000000000000073"},{"key":"2025122321350579000_33.1.50.16","doi-asserted-by":"crossref","DOI":"10.3310\/hta14080","article-title":"Dissemination and publication of research findings: an updated review of related biases","volume":"14","author":"Song","year":"2010","journal-title":"Health Technol Assess"},{"key":"2025122321350579000_33.1.50.17","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm-2022-003333"},{"key":"2025122321350579000_33.1.50.18","doi-asserted-by":"crossref","DOI":"10.1093\/omcr\/omx104","article-title":"Statin-induced rhabdomyolysis: a complication of a commonly overlooked drug interaction","volume":"2018","author":"Ezad","year":"2018","journal-title":"Oxf Med Case Reports"},{"key":"2025122321350579000_33.1.50.19","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2147\/DHPS.S333738","article-title":"A Narrative Review of Statin-Induced Rhabdomyolysis: Molecular Mechanism, Risk Factors, and Management","volume":"13","author":"Safitri","year":"2021","journal-title":"Drug Healthc Patient Saf"}],"container-title":["European Journal of Hospital Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ejhpharm-2024-004352","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T05:35:38Z","timestamp":1766554538000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejhp.bmj.com\/lookup\/doi\/10.1136\/ejhpharm-2024-004352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,8]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12,23]]},"published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1136\/ejhpharm-2024-004352"],"URL":"https:\/\/doi.org\/10.1136\/ejhpharm-2024-004352","relation":{},"ISSN":["2047-9956","2047-9964"],"issn-type":[{"value":"2047-9956","type":"print"},{"value":"2047-9964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,8]]}}}